Why I Chose the Name 'Discreet Ketamine'

People ask about the name. They hear "Discreet Ketamine" and they want to know the story. So here it is.

The idea started with a conversation between myself and my brother. We were talking about ketamine therapy: the research behind it, the patients it was helping, and the gap between how effective the treatment is and how few people actually pursue it. He identified something that I, as a physician, had been seeing from the clinical side but had not fully articulated. The barrier is not skepticism about whether ketamine works. For many people, the barrier is discomfort with how treatment is delivered.

He put it simply: "Wouldn't it be great if the service just came to you? Something truly discreet?"

That word stuck with me. Discreet. It captured exactly the problem I wanted to solve.

The Gap Between Evidence and Access

The clinical evidence for ketamine in treatment-resistant depression, anxiety, and PTSD is strong and growing. But evidence alone does not get patients into treatment. I was seeing a pattern: people who had read the research, who had tried multiple antidepressants without adequate relief, who understood that ketamine might help, but who could not bring themselves to walk into a clinic. For a deeper look at how ketamine compares to traditional options, see our article on ketamine vs. antidepressants.

The reasons varied, but a theme emerged. A healthcare worker in a small town did not want to be seen entering a ketamine clinic by a colleague or a patient. An executive worried that word would get back to his board. A mother did not want to explain to other parents at school pickup where she had been. A veteran felt that seeking mental health treatment conflicted with an identity he had built around self-reliance.

These are not trivial concerns. They are real, practical, human obstacles that prevent people from getting care they need.

Discreet Does Not Mean Ashamed

I want to be direct about this: choosing privacy is not the same as hiding. There is nothing shameful about treating depression, anxiety, PTSD, or chronic pain. Seeking help is not a weakness; it is a decision that takes clarity and courage.

The fact is that mental health treatment still carries social weight in many communities and professions. Until that changes fully, patients deserve a treatment model that respects their preference for privacy without requiring them to justify it.

The name "Discreet Ketamine" is not an endorsement of stigma. It is a recognition that stigma still exists, and a promise that we will not force our patients to deal with it as a condition of getting help.

What "Discreet" Looks Like in Practice

At Discreet Ketamine, discretion is not just a brand value; it is embedded in how we deliver care.

Your initial consultation with Dr. Ben Soffer, a board-certified physician, happens via secure telehealth. No waiting room. No check-in desk. No clipboard with your name on it.

Your medication arrives at your home by mail in standard packaging. Your treatment sessions happen in your own space, on your own schedule, with a peer supervisor you choose and trust.

Follow-up care, dose adjustments, and integration support all happen through our telehealth platform. There is no clinic to visit, no parking lot where someone might recognize your car, no sign-in sheet.

This is what at-home ketamine therapy looks like. It is professional, it is clinically rigorous, and it is private. For a full overview of our approach, see our guide on at-home ketamine therapy.

A Name That Keeps Its Promise

Every business name is a promise. Ours promises that you can access effective, physician-supervised ketamine treatment for depression, anxiety, PTSD, and chronic pain without sacrificing your privacy.

We serve patients in Florida and New Jersey, with treatment starting at $250/month. If that promise sounds like what you have been looking for, check your eligibility to get started.

Frequently Asked Questions

What does "Discreet Ketamine" actually mean for me as a patient?

It means the entire care pathway happens privately, without you having to walk into a clinic, sit in a waiting room, or be seen by anyone outside your household. Your consultation is a video call. Your prescription ships to your home in standard packaging. Your sessions happen in your own space, on your schedule, with a peer supervisor you choose. Follow-ups, dose adjustments, and integration support all run through telehealth. There is no clinic to visit, no staff who recognize your name, no parking lot where someone might see your car.

Is at-home ketamine therapy really as effective as a clinic visit?

For ongoing maintenance treatment of depression, anxiety, PTSD, and chronic pain, real-world outcomes are comparable. IV ketamine in a clinic delivers 100% bioavailability and is preferred for acute crisis (severe TRD with active suicidal ideation, where a 24-hour response is decisive). Sublingual at home delivers 25-35% bioavailability with the dose adjusted upward to compensate, and produces durable response when paired with proper integration work. Most patients who don't need acute crisis intervention do as well or better at home, in part because the privacy and familiarity of home settings supports the therapeutic work.

Who runs Discreet Ketamine and what are the credentials?

Dr. Ben Soffer, a board-certified physician licensed in Florida and New Jersey. Every consultation, prescription, and follow-up is reviewed by him personally. The medication is dispensed by a U.S.-licensed compounding pharmacy. The platform is HIPAA-compliant and built for the care, not for the marketing.

How much does it cost and is it covered by insurance?

Treatment starts at $250/month at Discreet Ketamine, which covers the physician consultation, prescription, and ongoing clinical oversight. Compounded medication from the pharmacy is separate and typically runs $100-$200/month depending on dose and frequency. Most all-in costs land at $350-$450/month. Insurance coverage for at-home compounded ketamine is rare; HSA and FSA dollars can typically be used. Spravato (esketamine) in a clinic setting is the only ketamine modality with realistic insurance coverage, but the at-home alternative is substantially cheaper out of pocket than co-payments for many Spravato programs.

What if I want to stop treatment? Am I locked in?

No. There are no long-term contracts. Patients can pause or stop treatment at any time, and many use ketamine as an induction-then-maintenance approach (an initial 4-8 week course, then occasional maintenance sessions) rather than ongoing monthly treatment. Your physician will help you plan the right cadence for your goals; the model is structured around clinical response, not around keeping you on a subscription.

Can my employer, insurance company, or family find out I'm doing this?

Your medical records are protected under HIPAA and are not visible to your employer or family without your consent. If you are paying out of pocket (which most at-home ketamine patients do), no claim is filed with your insurance, so there is no insurance-side record of treatment. The medication ships in plain packaging without provider branding. Privacy is the default, not an opt-in.

Why "discreet" instead of branding around success stories or transformation?

Because the patients I was seeing were not asking for a transformation story. They were asking for a way to get effective treatment without the social and professional cost of being seen as someone in mental health treatment. The name reflects what they actually wanted, not what marketing convention says a treatment brand is supposed to project. Healing happens regardless of branding; access is what was missing.

Disclaimer: Compounded ketamine for anxiety, depression, PTSD, and chronic pain is not FDA approved.